Stockreport

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Septerna, Inc.  (SEPN) 
PDF Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical Trial Ongoing [Read more]